Compositions and methods for detecting Atopobium vaginae
AssigneeMedical Diagnostic Laboratories, LLC
InventorsJason Trama, Martin E. Adelson, Eli Mordechai
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedical Diagnostic Laboratories, LLC
InventorsJason Trama, Martin E. Adelson, Eli Mordechai
Estimating the term…
Disclosed are oligonucleotides useful in methods for determining whether a sample contains Atopobium vaginae or has an increased likelihood of containing Atopobium vaginae, an organism which is seen in conjunction with bacterial vaginosis or is a causative agent of bacterial vaginosis. These oligonucleotides, which have nucleotide sequences derived from a segment of the genome of Atopobium vaginae, are useful as forward and reverse primers for a polymerase chain reaction using nucleic acids from a biological sample as a template, and as probes for detecting any resultant amplicon. Detection of an amplicon indicates the sample contains Atopobium vaginae or has an increased likelihood of containing Atopobium vaginae.
An isolated oligonucleotide sequence selected from the group consisting of SEQ ID NO:
An isolated oligonucleotide sequence selected from the group consisting of SEQ ID:
A composition comprising a first and a second isolated oligonucleotide, wherein the first oligonucleotide comprises SEQ ID NO:
A method for determining whether a sample contains Atopobium vaginae or has an increased likelihood of containing Atopobium vaginae comprising:
A composition comprising a first, a second and a third isolated oligonucleotide, wherein the first oligonucleotide comprises SEQ ID NO:
Dependencies are inferred from the claim text.